Status:
COMPLETED
Straberi Epistamp Needling Treatment For Skin Rejuvenation
Lead Sponsor:
Universal Skincare Institute
Collaborating Sponsors:
Lavish Beauty
Conditions:
Wrinkle
Elastic Skin
Eligibility:
All Genders
21-65 years
Phase:
NA
Brief Summary
This pilot study will expand knowledge and application needling using the Epistamp device for the improvement of a new vitalized epidermal layer with new vibrant active cells, supported by more robust...
Detailed Description
This pilot study will expand the knowledge and application needling using the Epistamp device and its benefits for improving the appearance of fine lines, deep wrinkles, and collagen production. The p...
Eligibility Criteria
Inclusion
- Derma Scan showing aging including skin texture, wrinkles, brown spots, and pores.
- Patients willing to sign informed consent.
- Patients willing to be photographed and video documented
- Patients willing to consent to 3 months of treatment
Exclusion
- History of eczema in the treatment area; psoriasis and any other chronic skin conditions
- History of actinic (solar) keratosis in the treatment area;
- History of hemophilia
- History of diabetes
- The presence of raised moles, warts on the targeted area.
- Collagen vascular diseases or cardiac abnormalities
- Blood clotting problems
- Active bacterial or fungal infection
- Facial melanosis
- Malignant tumors
- Immunosuppression
- Use of blood thinners or prednisone
- Corticosteroids within two weeks of the procedure
- Chronic liver disease
- Porphyria or other skin diseases.
- Patient not willing to sign informed consent.
- TCA peels in the last 5 weeks
- Subject currently has moderate to severe acne on the face.
- Microneedling within the last 6 months
- Subject has an active infection.
- Subject has a history of a bleeding disorder
- Subject has a history of keloidal tendency
- Subject has received ablative or non-ablative laser treatments in the previous 6 months.
- Subject has taken Accutane within the previous 3 months.
Key Trial Info
Start Date :
December 23 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 12 2023
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT04742803
Start Date
December 23 2022
End Date
October 12 2023
Last Update
December 6 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Lavish
New York, New York, United States, 10028